We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UK Pharma Industry Says Proposed Off-Label Guidance Risks Safety
UK Pharma Industry Says Proposed Off-Label Guidance Risks Safety
July 11, 2011
The UK pharmaceutical industry is raising concerns over the country’s General Medical Council (GMC) proposed guidance on prescribing off-label or unlicensed medicines.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor